Xinshuang Yu

5PUBLICATIONS
29CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 08, 2024
Neoadjuvant immunotherapy improves outcomes for resectable gastroesophageal junction cancer: A systematic review and meta-analysis.

Danzhu Wu, Liyuan Yang, Yu Yan

|Mar 01, 2024
Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites.

Yuzhu Hou, Kaiting Yang, Liangliang Wang

|Dec 27, 2022
The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer.

Peng Dong, Yu Yan, Yujun Fan

|Oct 10, 2022
Neoadjuvant Immunotherapy Improves Treatment for Early Resectable Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis.

Peng Dong, Yu Yan, Liyuan Yang

|Feb 25, 2021
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity.

Yuzhu Hou, Hua L Liang, Xinshuang Yu

Pageof 1

Frequent Collaborators

2 joint publications

Yuzhu Hou

2 joint publications

Hua Laura Liang

2 joint publications

Yajuan Lv

2 joint publications

Yu Yan